| __timestamp | Celldex Therapeutics, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 8393000000 |
| Thursday, January 1, 2015 | 100171000 | 7690000000 |
| Friday, January 1, 2016 | 102726000 | 7872000000 |
| Sunday, January 1, 2017 | 96171000 | 7657000000 |
| Monday, January 1, 2018 | 66449000 | 8006000000 |
| Tuesday, January 1, 2019 | 42672000 | 8650000000 |
| Wednesday, January 1, 2020 | 42534000 | 9405000000 |
| Friday, January 1, 2021 | 53311000 | 13829000000 |
| Saturday, January 1, 2022 | 82258000 | 11428000000 |
| Sunday, January 1, 2023 | 118011000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Pfizer Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. Pfizer, a global giant, consistently allocated substantial resources, peaking in 2021 with a 38% increase from 2014. This commitment underscores Pfizer's strategy to maintain its leadership in drug development. In contrast, Celldex, a smaller biotech firm, exhibited a more volatile R&D expenditure pattern, with a notable 64% drop from 2014 to 2019, followed by a resurgence in 2023. This fluctuation reflects the challenges and opportunities faced by smaller firms in navigating the competitive biotech sector. As the industry continues to innovate, understanding these spending trends offers valuable insights into the strategic priorities of pharmaceutical companies.
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.